Shanquan Chen: The London School of Hygiene & Tropical Medicine, London, UK
Feng Sha: Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong Province, China
Zhirong Yang: Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong Province, China
Submission Status: Open | Submission Deadline: 31 January 2024
BMC Medicine is calling for submissions to our Collection on Dementia prevention and therapies.
Dementia refers to syndrome associated with a decline in memory and neurocognitive function. The Global Dementia Observatory estimates that there are currently 55.2 million people living with some form of Dementia. Aging tends to be a major risk factor for development of Dementia with risk increasing from 1 in 14 for those aged over 65 to 1 in 6 for those over the age of 80. Partially because of individuals living longer lives this poses a major concern for society. As such the number of people living with Dementia are predicted to rise from 55 million to 139 million by the year 2050. This presents a major threat to health globally as recognised by the UN’s aim of 2021-2030 decade of improving the lives of older people. There is a clear need for a focus on interventions across the board which can help to address dementia progression.